Total Payments
$2.0M
2024 Payments
$264,389
Companies
70
Transactions
4,134
Medicare Patients
8,007
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$1.4M (69.7%)
Consulting$314,128 (15.6%)
Travel$205,952 (10.3%)
Food & Beverage$87,676 (4.4%)
Research$1,270 (0.1%)
Education$528.74 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $913,939 | 388 | 45.5% |
| Honoraria | $480,082 | 218 | 23.9% |
| Consulting Fee | $314,128 | 128 | 15.6% |
| Travel and Lodging | $205,952 | 623 | 10.3% |
| Food and Beverage | $87,676 | 2,753 | 4.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,245 | 1 | 0.3% |
| Unspecified | $1,270 | 2 | 0.1% |
| Education | $528.74 | 21 | 0.0% |
Payments by Type
General
$2.0M
4,132 transactions
Research
$1,270
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $473,938 | 858 | $0 (2024) |
| Horizon Therapeutics plc | $370,043 | 444 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $256,898 | 434 | $0 (2024) |
| Amgen Inc. | $220,631 | 509 | $0 (2024) |
| Horizon Pharma plc | $132,223 | 172 | $0 (2018) |
| PFIZER INC. | $115,974 | 253 | $0 (2024) |
| GENZYME CORPORATION | $93,367 | 126 | $0 (2024) |
| Lilly USA, LLC | $84,884 | 168 | $0 (2024) |
| Celgene Corporation | $79,674 | 113 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $77,830 | 115 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $264,389 | 451 | ABBVIE INC. ($79,391) |
| 2023 | $249,396 | 461 | AbbVie Inc. ($95,079) |
| 2022 | $271,437 | 580 | Horizon Therapeutics plc ($107,934) |
| 2021 | $142,007 | 411 | Horizon Therapeutics plc ($70,502) |
| 2020 | $170,495 | 376 | Horizon Therapeutics plc ($39,737) |
| 2019 | $344,035 | 708 | AbbVie, Inc. ($80,273) |
| 2018 | $330,400 | 605 | Horizon Pharma plc ($88,367) |
| 2017 | $236,663 | 542 | Novartis Pharmaceuticals Corporation ($61,104) |
All Payment Transactions
4,134 individual payment records from CMS Open Payments — Page 1 of 166
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Pacira Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $5,040.00 | General |
| 12/27/2024 | Pacira Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $3,780.00 | General |
| 12/27/2024 | Pacira Pharmaceuticals Incorporated | — | Travel and Lodging | Cash or cash equivalent | $595.00 | General |
| 12/26/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation | ||||||
| 12/26/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $551.25 | General |
| Category: Inflammation | ||||||
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/20/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Bone Health | ||||||
| 12/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $38.85 | General |
| Category: Inflammation | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $10.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $7.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/16/2024 | Eli Lilly and Company | TALTZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $43.12 | General |
| Category: Rheumatology | ||||||
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Analgesic | ||||||
| 12/05/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,270 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,935 | 7,064 | $1.7M | $279,980 |
| 2022 | 19 | 2,014 | 5,774 | $1.8M | $305,350 |
| 2021 | 21 | 2,120 | 6,775 | $1.8M | $308,923 |
| 2020 | 20 | 1,938 | 5,464 | $1.5M | $256,354 |
Total Patients
8,007
Total Services
25,077
Medicare Billing
$1.2M
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 648 | 1,256 | $777,464 | $127,517 | 16.4% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 40 | 85 | $269,220 | $46,630 | 17.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 130 | 172 | $148,608 | $25,795 | 17.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 79 | 79 | $83,345 | $14,535 | 17.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 95 | 201 | $65,254 | $11,707 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $64,080 | $10,028 | 15.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 74 | 90 | $55,440 | $9,435 | 17.0% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2023 | 19 | 1,740 | $62,160 | $8,697 | 14.0% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 11 | 608 | $46,208 | $7,831 | 16.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 447 | 681 | $10,910 | $5,695 | 52.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 70 | 75 | $32,925 | $5,590 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 40 | $17,560 | $2,730 | 15.5% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 33 | 42 | $11,396 | $1,801 | 15.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 111 | $7,770 | $1,203 | 15.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 128 | 964 | $4,820 | $785.44 | 16.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 840 | $0.14 | $0.12 | 85.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 654 | 1,322 | $822,284 | $135,744 | 16.5% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2022 | 53 | 102 | $362,916 | $61,236 | 16.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 119 | 161 | $140,553 | $23,538 | 16.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 73 | 73 | $77,672 | $12,877 | 16.6% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2022 | 14 | 1,140 | $51,840 | $12,630 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $59,570 | $9,741 | 16.4% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2022 | 14 | 736 | $58,144 | $9,593 | 16.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 83 | 101 | $44,440 | $7,579 | 17.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 63 | 72 | $44,784 | $7,577 | 16.9% |
About Dr. Orrin Troum, MD
Dr. Orrin Troum, MD is a Rheumatology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821032608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Orrin Troum, MD has received a total of $2.0M in payments from pharmaceutical and medical device companies, with $264,389 received in 2024. These payments were reported across 4,134 transactions from 70 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($913,939).
As a Medicare-enrolled provider, Troum has provided services to 8,007 Medicare beneficiaries, totaling 25,077 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Santa Monica, CA
- Active Since 06/15/2006
- Last Updated 04/20/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821032608
Products in Payments
- KRYSTEXXA (Biological) $350,075
- RINVOQ (Biological) $211,717
- COSENTYX (Biological) $203,280
- KRYSTEXXA (Drug) $116,019
- Otezla (Drug) $107,476
- Enbrel (Biological) $91,750
- TALTZ (Drug) $78,456
- RAYOS (Drug) $66,502
- SKYRIZI (Biological) $61,503
- XELJANZ (Drug) $61,253
- ORENCIA (Biological) $60,888
- KEVZARA (Drug) $42,016
- KEVZARA (Biological) $40,852
- Humira (Biological) $35,698
- Rinvoq (Biological) $29,746
- ENBREL (Biological) $24,159
- RINVOQ (Drug) $20,104
- TREMFYA (Drug) $13,009
- BENLYSTA (Biological) $10,701
- UPLIZNA (Biological) $8,063
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Santa Monica
Elyse Rubenstein, Md, MD
Rheumatology — Payments: $18,211
Rheumatology $18,211
Dr. Thomas Susko, M.d, M.D
Rheumatology — Payments: $14,685
Rheumatology $14,685
Dr. Katy Setoodeh, M.d, M.D
Rheumatology — Payments: $10,630
Rheumatology $10,630
Amy Kehl, Md, MD
Rheumatology — Payments: $6,709
Rheumatology $6,709
Howard Yang, Md, MD
Rheumatology — Payments: $2,002
Rheumatology $2,002
Kristal Choi, M.d, M.D
Rheumatology — Payments: $1,881
Rheumatology $1,881